Socioeconomic status and longitudinal neurocognitive outcomes following childhood brain tumor diagnosis: A Swedish national population-based cohort study
Open Access
- 8 October 2026
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
Abstract
Background: Lower socioeconomic status (SES) is linked to poorer neurocognitive development in the general population, but these effects in pediatric brain tumor survivors are underexplored. We examined the relationship between parental SES, clinical factors, and neurocognitive functioning longitudinally up to 5 years post-diagnosis and determined whether young children were more vulnerable. Methods: This population-based registry study included Swedish children diagnosed with brain tumors between 2008 and 2023 and who completed ≥2 neurocognitive assessments. Parental education, occupation, and household income were used as individual SES indicators as well as a combined SES measure. Linear mixed models examined relationships between SES and age at diagnosis on neurocognitive outcomes, accounting for time since diagnosis, chemotherapy, and radiotherapy. Results: We included 461 children (mean age at diagnosis = 7.98 years, SD = 4.01). Higher SES was associated with higher neurocognitive z-scores on processing speed (B = 0.23), working memory (B = 0.25), nonverbal reasoning (B = 0.29), verbal reasoning (B = 0.41), and global cognition (B = 0.42; q’s ≤ .039). No interactions between SES and age or time were observed. Longer time since diagnosis was associated with lower processing speed (B = −0.04) and verbal reasoning (B = −0.05; q’s ≤ .041). Younger age at diagnosis was related to steeper declines in nonverbal reasoning (B = 0.01, q = .016). Cranio-spinal irradiation was related to lower processing speed (B = −0.50, q = .019). Conclusions: In Swedish childhood brain tumor survivors, lower SES was associated with poorer neurocognitive functioning over time. The absence of socioeconomic differences in rate of decline suggests that lower SES may reduce baseline cognitive reserve rather than amplifying disease or treatment-related toxicity.Keywords
Funding Information
- Horizon Europe/Marie Skłodowska-Curie Action co-fund (101081481)
- the Irene Stichting, and the Swedish Childhood Cancer Fund (FT2023-0007)
This publication has 41 references indexed in Scilit:
- Assessing Cognitive Functioning in Children With Brain Tumors: Interaction of Neighborhood Social Determinants of Health and Neurological RiskPediatric Blood & Cancer, 2026
- Comparisons between individual- and area-level measures of socioeconomic status among childhood cancer patients: A report from the Children’s Oncology Group (COG)Cancer Epidemiology, 2026
- Cognitive and adaptive functioning outcomes after cancer diagnosis in early childhood: A systematic reviewEJC Paediatric Oncology, 2025
- Neuropsychological Outcomes in Pediatric Brain Tumor Survivors2024
- A systematic review of interventions for neurocognitive dysfunctions in patients and survivors of a pediatric brain tumorPediatric Blood & Cancer, 2024
- Incidence and survival of childhood central nervous system tumors in Denmark, 1997–2019Cancer Medicine, 2021
- Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomesNeuropsychology Review, 2017
- Children and Socioeconomic Status2015
- Risk factors for cognitive decline in children treated for brain tumorsEuropean Journal of Paediatric Neurology, 2010
- Neurocognitive effects of treatment for childhood cancerMental Retardation and Developmental Disabilities Research Reviews, 2006